These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37000126)

  • 1. Cannabis update: Anxiety disorders and post-traumatic stress disorder.
    Haycraft AL
    J Am Assoc Nurse Pract; 2023 May; 35(5):276-280. PubMed ID: 37000126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal cannabis for the treatment of anxiety disorders.
    Berger M; Amminger GP; McGregor IS
    Aust J Gen Pract; 2022 Aug; 51(8):586-592. PubMed ID: 35908759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
    Stanciu CN; Brunette MF; Teja N; Budney AJ
    Psychiatr Serv; 2021 Apr; 72(4):429-436. PubMed ID: 33530732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ∆
    Raymundi AM; da Silva TR; Sohn JMB; Bertoglio LJ; Stern CA
    BMC Psychiatry; 2020 Aug; 20(1):420. PubMed ID: 32842985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ
    Peters EN; MacNair L; Mosesova I; Christians U; Sempio C; Klawitter J; Land MH; Ware MA; Turcotte C; Bonn-Miller MO
    Eur J Clin Pharmacol; 2022 Feb; 78(2):259-265. PubMed ID: 34664109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.
    Forsythe ML; Boileau AJ
    J Basic Clin Physiol Pharmacol; 2021 Mar; 33(2):121-132. PubMed ID: 33662194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
    Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.
    Pichini S; Mannocchi G; Berretta P; Zaami S; Pirani F; Pacifici R; Busardò FP
    Ther Drug Monit; 2020 Feb; 42(1):151-156. PubMed ID: 31389860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cannabidiol pharmacotherapy for delta-9-tetrahidrocannabinol dependence].
    Pavlovsky F; Groisman R; Hurtado AK; García L
    Vertex; 2022 Oct; 33(157):34-43. PubMed ID: 36219190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.